SUBDURAL HEMORRHAGE

Definition and Pathophysiology of Subdural Hemorrhage

Subdural Hemorrhage (SDH) represents a critical form of intracranial bleeding characterized by the accumulation of blood in the subdural space, which is situated between the protective layers of the brain: the outermost dura mater and the underlying arachnoid mater. This condition is fundamentally a consequence of physical damage to the intricate cerebral vasculature, most commonly resulting from significant acceleration or deceleration forces impacting the cranium. These forces cause a shearing stress upon the delicate bridging veins that traverse the subdural space, connecting the cerebral cortex to the dural venous sinuses. When these veins rupture, blood slowly or rapidly leaks into the potential subdural area, forming a hematoma that exerts pressure on the underlying brain tissue.

The core mechanism involves trauma, where the brain, suspended in cerebrospinal fluid, moves relative to the fixed dura mater. This differential movement places tremendous tension on the bridging veins, particularly where they penetrate the dura. The severity of the resulting neurological deficit is directly correlated not only with the initial injury but also with the rate and volume of blood accumulation. Rapidly expanding hematomas lead to acute increases in intracranial pressure (ICP), potentially causing herniation, a life-threatening displacement of brain tissue. Unlike epidural hematomas, which involve arterial bleeding and are often localized, SDH typically involves venous bleeding, which can spread widely over the hemispheric surface, making the resulting mass effect widespread and insidious in its onset, particularly in chronic cases.

Understanding the anatomical context is vital for appreciating the pathophysiology. The dura mater is tightly adhered to the inner surface of the skull, while the arachnoid mater is a delicate membrane lying close to the brain surface. The subdural space is not a true anatomical space but rather a potential space created by pathology, allowing the blood to pool and compress neural structures. This compression compromises the blood supply to affected regions and directly interferes with neuronal function, leading to the varied and severe symptoms observed in patients, including the problems with speech and vision mentioned in preliminary assessments. Furthermore, the presence of blood breakdown products within the subdural space can trigger chronic inflammatory and osmotic processes, which are particularly relevant in the development of chronic subdural hematomas, where the hematoma may expand over weeks or months, even without recurrent bleeding.

Classification and Temporal Dynamics

Subdural hemorrhages are clinically classified based on the time elapsed between the inciting trauma and the onset of symptoms, dictating the urgency and approach to treatment. The three main categories—acute, subacute, and chronic—reflect different pathological processes, clinical presentations, and necessary therapeutic interventions. An acute subdural hemorrhage (aSDH) is defined by symptom presentation occurring within the first 72 hours following the traumatic event. These are typically the most immediately catastrophic injuries, often associated with severe underlying brain parenchymal damage and high mortality rates. Due to the rapid accumulation of fresh, clotted blood, acute SDH quickly leads to elevated intracranial pressure and profound neurological deterioration, demanding immediate surgical evacuation.

The category of subacute subdural hemorrhage encompasses cases where symptoms manifest between three days and three weeks post-injury. In this phase, the clot begins to undergo lysis and dissolution, changing consistency and density on imaging studies. While less immediately fulminant than acute cases, subacute SDH still presents significant risk of neurological decline. The patient may initially appear stable following the trauma, only to experience gradual worsening of headache, confusion, or focal neurological deficits as the hematoma evolves. The management strategy during this subacute window often balances close neurological monitoring with surgical intervention if the hematoma continues to exert a significant mass effect or if the patient’s condition deteriorates.

A chronic subdural hemorrhage (cSDH) is diagnosed when symptoms appear more than three weeks after the initial trauma, which may have been so minor that the patient often cannot recall the injury. Chronic SDH is particularly prevalent in the elderly. Over time, the clotted blood within the subdural space organizes, forming internal and external membranes. Osmotic gradients often draw fluid into the hematoma cavity, causing the lesion to expand slowly and chronically compress the brain. The symptoms of chronic SDH are often vague and can mimic other conditions, such as dementia or stroke, including generalized confusion, gait disturbance, and mild hemiparesis. This slow, gradual evolution underscores why continuous neurological assessment is critical, even after seemingly minor head injuries, especially in vulnerable populations.

Etiology and Predisposing Risk Factors

The primary etiology of subdural hemorrhage is traumatic brain injury (TBI). In younger, healthier individuals, SDH typically results from high-velocity trauma, such as motor vehicle accidents, severe falls, or assault, generating the powerful shearing forces necessary to tear the bridging veins. However, the spectrum of causes widens significantly when considering populations with predisposing risk factors, where even minimal trauma can precipitate bleeding. One tragic cause in infants is shaken baby syndrome, where the violent, repetitive acceleration and deceleration forces cause catastrophic vascular damage.

A vast array of systemic and anatomical factors increases an individual’s susceptibility to SDH, making it crucial to evaluate a patient’s complete medical history. The use of anticoagulant and antiplatelet medications (such as warfarin or aspirin) dramatically elevates the risk, as these therapies impair the body’s ability to form a stable clot, allowing minor bleeds to expand rapidly into clinically significant hematomas. Furthermore, conditions leading to cerebral atrophy, such as chronic alcoholism, advancing age, and neurodegenerative disorders, increase the physical space between the brain surface and the dura mater. This expansion stretches the bridging veins, making them taut and highly vulnerable to rupture even from minor, incidental trauma that would be insignificant in a younger, healthy brain.

Other less common but critical risk factors include underlying structural anomalies, such as arteriovenous malformations, or conditions leading to coagulopathy, like severe liver disease or congenital clotting factor deficiencies. Iatrogenic causes, such as procedures involving rapid decompression of cerebrospinal fluid (e.g., following spinal taps or shunt placement), can also precipitate SDH by causing the brain to descend slightly, again putting tension on the bridging veins. Recognition of these underlying risk factors is paramount not only for diagnosis but also for subsequent therapeutic management, as it informs decisions regarding reversal of anticoagulation and necessary long-term preventative care.

Clinical Presentation and Symptomatology

The clinical manifestations of subdural hemorrhage are notoriously variable, depending heavily on the size and location of the hematoma, the rate of accumulation, and the underlying pre-morbid neurological status of the patient. In acute SDH, the onset is rapid and devastating, often presenting with a rapid decline in the level of consciousness, measured by the Glasgow Coma Scale (GCS), indicative of severe brain compression. Patients may exhibit signs of critically elevated ICP, including vomiting, bradycardia, hypertension (Cushing’s triad), and pupillary changes, such as unilateral pupil dilation, signaling impending uncal herniation.

The original content specifically highlighted problems in speech and vision, which are examples of focal neurological deficits resulting from the compression of specific cortical areas. A hematoma compressing the frontal or temporal lobes of the dominant hemisphere may result in aphasia (difficulty producing or understanding language), severely impairing speech communication. Compression of the occipital cortex or optic pathways can lead to visual field deficits, known as hemianopsia. Other common focal signs include hemiparesis (weakness on one side of the body) or hemiplegia (paralysis), which results from pressure on the primary motor cortex or descending motor tracts.

In contrast, chronic SDH symptoms are often subtle, fluctuating, and generalized, making diagnosis challenging. Patients may complain of persistent, non-specific headaches, mild confusion, or general malaise. Behavioral and cognitive changes are particularly relevant in the context of psychological study. These changes can include slowness of thought, apathy, poor executive function, and personality changes that are often mistakenly attributed to aging or psychiatric conditions. Seizures, both focal and generalized, can also occur due to irritation of the cortex by the underlying hematoma. The comprehensive list of potential neurological and psychological symptoms underscores the need for high clinical suspicion, particularly in elderly patients who present with unexplained cognitive decline or gait instability.

• Altered Mental Status: Ranging from mild confusion and somnolence to deep coma.
• Focal Motor Deficits: Weakness or paralysis (hemiparesis/hemiplegia) contralateral to the hematoma location.
• Language Disturbances: Expressive or receptive aphasia due to dominant hemisphere compression.
• Visual Field Cuts: Hemianopsia resulting from visual pathway compression.
• Persistent Headache: Often the most common symptom, particularly in subacute and chronic cases.

Diagnostic Procedures and Neuroimaging

The definitive diagnosis of subdural hemorrhage relies primarily on rapid and accurate neuroimaging, supported by a thorough clinical neurological examination. The initial screening tool of choice, especially in the acute setting, is the Computed Tomography (CT) scan of the head. CT is rapid, widely available, and highly sensitive to acute blood collections. Acute SDH appears as a hyperdense (bright white) crescent-shaped collection conforming to the inner surface of the dura. The CT density changes over time, aiding in classification: subacute bleeds become isodense (appearing similar to the brain parenchyma), making them transiently harder to spot, while chronic bleeds appear hypodense (dark), reflecting the breakdown of hemoglobin and accumulation of serous fluid.

While CT is excellent for rapid assessment and surgical planning, Magnetic Resonance Imaging (MRI) offers superior tissue contrast and is often utilized in the evaluation of subacute or chronic hemorrhages, or when the initial CT scan is inconclusive, particularly regarding isodense hematomas. MRI provides clearer visualization of the membranes surrounding chronic hematomas, the relationship of the clot to the underlying brain surface, and can detect underlying associated injuries, such as cortical contusions. Additionally, certain MRI sequences (like susceptibility-weighted imaging) are extremely sensitive to blood products, confirming the presence of hemorrhage even when the CT findings are subtle.

Beyond imaging, the clinical assessment is crucial. The initial evaluation involves immediate assessment of the patient’s airway, breathing, and circulation, followed by a detailed neurological examination, including pupil reactivity and the assignment of a GCS score to quantify the level of consciousness. Laboratory tests, including a complete blood count and coagulation profile, are necessary to identify potential risk factors, such as thrombocytopenia or coagulopathy, which require immediate reversal before or during surgical intervention. The integration of clinical findings (e.g., history of trauma, specific neurological deficits) with the precise anatomical information provided by neuroimaging allows for timely and appropriate management decisions.

Treatment Modalities and Surgical Intervention

The management of subdural hemorrhage is highly individualized, dictated by the hemorrhage classification, the patient’s clinical status, and the size and mass effect of the hematoma. Small, asymptomatic chronic or subacute hemorrhages, particularly those without significant midline shift or mass effect, may be managed conservatively. Conservative management involves close neurological monitoring, serial neuroimaging (repeat CT scans), strict blood pressure control, and, critically, reversal of any underlying coagulopathy. The goal is to allow the body to resorb the blood collection naturally, often supported by corticosteroid therapy in some chronic cases, though this remains controversial.

Surgical intervention is mandatory for acute SDH associated with significant mass effect, rapid neurological deterioration, or those exceeding a specified thickness (typically 10mm) or causing a severe midline shift (typically 5mm). The gold standard for evacuation is the craniotomy, involving the removal of a large section of the skull to gain wide access to the subdural space. This allows for complete evacuation of the solid clot, meticulous control of any bleeding vessels, and direct visualization of the underlying brain. Craniotomy is highly effective for acute clots but carries risks associated with major neurosurgery.

For chronic subdural hematomas, which consist primarily of liquid or non-clotted fluid, less invasive procedures are often employed. The most common technique is burr hole trephination, where one or two small holes are drilled into the skull, and a drainage catheter is inserted into the subdural space to allow gravity or suction to evacuate the liquid collection. This procedure is less traumatic than a full craniotomy and is often highly effective for draining the encapsulated fluid of cSDH. Post-operative care involves meticulous monitoring of intracranial pressure and management of potential complications, such as re-accumulation of the hematoma, infection, or seizures.

Prognosis and Long-Term Psychological Sequelae

The prognosis following subdural hemorrhage is highly variable and depends on numerous factors, including the patient’s age, the severity of the initial injury, the GCS score upon presentation, and the presence of underlying brain injury. Acute SDH carries a guarded prognosis, often resulting in significant mortality or severe long-term disability, particularly if surgical intervention is delayed. Conversely, the prognosis for chronic SDH, especially when diagnosed early and treated effectively with drainage, is often favorable, with many patients achieving good functional outcomes, although recurrence rates remain a concern.

Crucially, from a psychological perspective, even successfully treated SDH can lead to lasting neurocognitive deficits and psychiatric morbidity. The compression and subsequent swelling of brain tissue can result in permanent damage to areas governing higher-order function. Patients often struggle with executive dysfunction, manifesting as difficulty with planning, abstract reasoning, impulse control, and organization, significantly impacting their ability to return to work or independent living. Memory impairment and attention deficits are also highly common post-SDH sequelae.

Furthermore, SDH survivors face elevated rates of psychiatric complications, including major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder (PTSD), particularly if the injury resulted from a violent event. These emotional and behavioral changes are complex, stemming both from the direct neurological damage and the psychological distress associated with the trauma, hospitalization, and subsequent rehabilitation process. Therefore, comprehensive rehabilitation for SDH survivors must integrate aggressive physical, occupational, and speech therapy with specialized neuropsychological evaluation and psychiatric support to address the full spectrum of recovery needs.

Special Considerations: The Geriatric Population

The elderly population warrants specific consideration in the context of subdural hemorrhage, as they represent the group most susceptible to chronic forms of the condition. Due to age-related cerebral atrophy, the brain shrinks, increasing the tension on the bridging veins and making them susceptible to rupture from minor, often forgotten, falls. This physiological change means that geriatric patients frequently develop cSDH without a clear history of significant trauma, leading to diagnostic challenges where symptoms are mistakenly attributed to natural aging or neurodegenerative diseases like Alzheimer’s.

The typical presentation of chronic SDH in the geriatric patient is often subtle, insidious, and non-localizing, frequently characterized by subacute onset of confusion, progressive gait disturbance (ataxia), or urinary incontinence—a symptom triad that commonly mimics normal pressure hydrocephalus or dementia. The slow expansion of the hematoma allows the brain to partially accommodate the mass effect, delaying the onset of severe focal deficits. However, the cumulative effect of compression exacerbates pre-existing cognitive deficits, leading to functional decline and increased dependency.

Because of this diagnostic challenge, a high index of suspicion is required for any elderly patient presenting with unexplained new-onset confusion, cognitive decline, or gait instability, necessitating prompt CT scanning. Furthermore, the management of SDH in the elderly requires careful balancing of surgical risks versus benefits, given common comorbidities and potential complications related to anesthesia and prolonged immobility. Despite these risks, surgical evacuation of cSDH in the elderly often yields dramatic clinical improvement, significantly enhancing their quality of life and functional independence.